✦ LIBER ✦

Phase I study of irinotecan and doxifluridine for metastatic colorectal cancer focusing on the UGT1A1*28 polymorphism

✍ Scribed by Shoichi Hazama; Atsushi Nagashima; Hiroshi Kondo; Shin Yoshida; Ryoichi Shimizu; Atsuhiro Araki; Shigefumi Yoshino; Naoko Okayama; Yuji Hinoda; Masaaki Oka

Book ID: 108586601
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 156 KB
Volume: 101
Category: Article
ISSN: 1347-9032
DOI: 10.1111/j.1349-7006.2009.01428.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The Role of UGT1A1*28 Polymorphism in th

The Role of UGT1A1*28 Polymorphism in the Pharmacodynamics and Pharmacokinetics of Irinotecan in Patients With Metastatic Colorectal Cancer

✍ Toffoli, G. 📂 Article 📅 2006 🏛 American Society of Clinical Oncology 🌐 English ⚖ 104 KB

Phase I/II study of sequential therapy w

Phase I/II study of sequential therapy with irinotecan and S-1 for metastatic colorectal cancer

✍ Yoshioka, T; Kato, S; Gamoh, M; Chiba, N; Suzuki, T; Sakayori, N; Kato, S; Shiba 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 257 KB

Predictive Role of the UGT1A1, UGT1A7, a

Predictive Role of the UGT1A1, UGT1A7, and UGT1A9 Genetic Variants and Their Haplotypes on the Outcome of Metastatic Colorectal Cancer Patients Treated With Fluorouracil, Leucovorin, and Irinotecan

✍ Cecchin, E.; Innocenti, F.; D'Andrea, M.; Corona, G.; De Mattia, E.; Biason, P.; 📂 Article 📅 2009 🏛 American Society of Clinical Oncology 🌐 English ⚖ 134 KB

A pilot study on the safety of combining

A pilot study on the safety of combining chrysin, a non-absorbable inducer of UGT1A1, and irinotecan (CPT-11) to treat metastatic colorectal cancer

✍ Peter J. Tobin; Philip Beale; Leesa Noney; Sandy Liddell; Laurent P. Rivory; Ste 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 238 KB

The genotyping of UGT1A1 polymorphism fo

The genotyping of UGT1A1 polymorphism for the dose adjustment of irinotecan in metastatic colorectal cancer patients treated with FOLFIRI plus bevacizumab as the first-line regimen

✍ Lu, Chien-Yu; Tsai, Hsiang-Lin; Wang, Jaw-Yuan 📂 Article 📅 2013 🏛 Elsevier 🌐 English ⚖ 169 KB

Phase I/II Pharmacokinetic and Pharmacog

Phase I/II Pharmacokinetic and Pharmacogenomic Study of UGT1A1 Polymorphism in Elderly Patients With Advanced Non–Small Cell Lung Cancer Treated With Irinotecan

✍ Yamamoto, N; Takahashi, T; Kunikane, H; Masuda, N; Eguchi, K; Shibuya, M; Takeda 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 230 KB